Pharmaceutical CAS 169590-41-4 Deracoxib Powder Deracoxib

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: QS-Deracoxib
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Deracoxib
• Name: Deracoxib Powder
• Appearance: White Powder
• Colour: White
• Grade: Pharmaceutical Grade
• Assay: >99%
• Application: API
• Specific: COA
• Test Method: HPLC
• Mf: C17h14f3n3o3s
• MW: 397.372
• Density: 1.48
• Melting Point: 159-161 C
• Boiling Point: 760 Mmhg
• CAS: 169590-41-4
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-Deracoxib
• Origin: Xian
• Production Capacity: 500kg/Month

Product Description

Pharmaceutical CAS 169590-41-4 Deracoxib Powder Deracoxib

Product Description

Product Details

Product Name	Deracoxib
Appearance	White Powder
Assay	99%
MW	397.372
MF	C17H14F3N3O3S

Deracoxib is a COX-2 selective inhibitor and belongs to nonsteroidal anti-inflammatory drugs (NSAIDs).
Deracoxib is mainly used to control postoperative pain and inflammation associated with soft tissue surgery, as well as to treat bladder transitional cell carcinoma in dogs. It works by selectively inhibiting COX-2 enzyme, reducing the production of prostaglandins, thereby alleviating inflammation and pain. Due to its selective effect, Deracoxib may have better gastrointestinal safety compared to traditional nonsteroidal anti-inflammatory drugs.

Application&Function

Dilacaoxib is a COX-2 selective inhibitor, which means it can selectively inhibit the activity of cyclooxygenase-2 (COX-2). COX-2 plays a crucial role in physiological processes such as inflammation, pain perception, and fever. When the body is damaged or inflamed, the expression of COX-2 increases, promoting the synthesis of inflammatory mediators such as prostaglandins, which in turn triggers inflammatory reactions and pain sensations. Dilacaoxib exerts anti-inflammatory, analgesic, and antipyretic effects by inhibiting COX-2 and reducing prostaglandin synthesis.
Non anesthetic and nonsteroidal anti-inflammatory properties
It belongs to non anesthetic, non steroidal anti-inflammatory compounds. Unlike anesthetics and analgesics, Diclofenac does not produce addictive or respiratory inhibitory side effects, and can ensure the safety and normal physiological function of patients while relieving pain. Compared with steroidal anti-inflammatory drugs, Dilaxib does not have many adverse reactions of steroidal drugs, such as endocrine disorders, immune suppression, etc., providing a safer and more effective choice for the treatment of inflammation and pain.

Specification